Range of suitable clients: CDEC reviewed the uncertainty in the number of people with moderately significant to severe hemophilia B in Canada suitable for etranacogene dezaparvovec. Clinical experts consulted by CADTH indicated that some people who will be labeled as possessing mild or reasonable illness can have a intense bleeding https://hemgenix71725.blogkoo.com/what-does-hemgenix-mean-55147346